SE7601535L - Injicerbara antibiotiska kompositioner - Google Patents
Injicerbara antibiotiska kompositionerInfo
- Publication number
- SE7601535L SE7601535L SE7601535A SE7601535A SE7601535L SE 7601535 L SE7601535 L SE 7601535L SE 7601535 A SE7601535 A SE 7601535A SE 7601535 A SE7601535 A SE 7601535A SE 7601535 L SE7601535 L SE 7601535L
- Authority
- SE
- Sweden
- Prior art keywords
- dispersing agent
- compositions
- injectible
- amoxycillin
- antibiotic compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000003115 biocidal effect Effects 0.000 title 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 abstract 3
- 239000002270 dispersing agent Substances 0.000 abstract 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229960003022 amoxicillin Drugs 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 239000010419 fine particle Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9515/75A GB1532993A (en) | 1975-03-07 | 1975-03-07 | Injectable antibiotic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7601535L true SE7601535L (sv) | 1976-09-08 |
| SE425762B SE425762B (sv) | 1982-11-08 |
Family
ID=9873459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7601535A SE425762B (sv) | 1975-03-07 | 1976-02-11 | Forfarande for framstellning av en komposiotion innehallande amoxicillintrihydrat i form av ett pulver, som kan rekonstitueras till en injicerbar komposition genom tillsats av en vattenhaltig berare |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4876086A (sv) |
| JP (1) | JPS5914004B2 (sv) |
| AR (1) | AR211700A1 (sv) |
| AT (1) | AT344317B (sv) |
| AU (1) | AU502790B2 (sv) |
| BE (1) | BE839109A (sv) |
| CA (1) | CA1045549A (sv) |
| DD (1) | DD124866A5 (sv) |
| DE (1) | DE2608079C2 (sv) |
| DK (1) | DK153123C (sv) |
| FI (1) | FI760503A7 (sv) |
| FR (1) | FR2302736A1 (sv) |
| GB (1) | GB1532993A (sv) |
| GR (1) | GR59302B (sv) |
| HU (1) | HU170250B (sv) |
| IE (1) | IE42951B1 (sv) |
| IL (1) | IL49009A (sv) |
| IT (1) | IT1061681B (sv) |
| MX (1) | MX5599E (sv) |
| NL (1) | NL187835C (sv) |
| NO (1) | NO760767L (sv) |
| NZ (1) | NZ179948A (sv) |
| PT (1) | PT64813B (sv) |
| SE (1) | SE425762B (sv) |
| ZA (1) | ZA76926B (sv) |
| ZM (1) | ZM2076A1 (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL53617A0 (en) * | 1976-12-17 | 1978-03-10 | Scherico Ltd | Improvements in or relating to antibiotic formulations |
| EP0008905B1 (en) * | 1978-09-06 | 1983-02-16 | Beecham Group Plc | Pharmaceutical compositions containing two beta-lactam derivatives |
| DE2965732D1 (en) * | 1978-12-08 | 1983-07-28 | Beecham Group Plc | Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition |
| EP0080862B1 (en) * | 1981-12-02 | 1985-09-25 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
| FR2594334B1 (fr) * | 1986-02-20 | 1990-01-12 | Bristol Myers Co | Composition pharmaceutique injectable a base d'amoxicilline |
| GB8629481D0 (en) * | 1986-12-10 | 1987-01-21 | Beecham Group Plc | Veterinary treatment |
| US4898728A (en) * | 1988-04-07 | 1990-02-06 | Beecham Group P.L.C. | Process for production of composition containing lecithin and polyvinylpyrrolidone |
| IT1230095B (it) * | 1989-04-27 | 1991-10-05 | Parenta Srl | Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici. |
| MX9201782A (es) * | 1991-04-19 | 1992-10-01 | Sandoz Ag | Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene. |
| US6447806B1 (en) | 1999-02-25 | 2002-09-10 | Novartis Ag | Pharmaceutical compositions comprised of stabilized peptide particles |
| AU2869100A (en) * | 1999-02-26 | 2000-09-14 | Biovail International Ltd. | Storage stable amoxycillin and clavulanate suspension composition |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB660511A (en) * | 1948-07-14 | 1951-11-07 | Squibb & Sons Inc | Penicillin compositions and methods of preparing them |
| GB705343A (en) * | 1952-02-01 | 1954-03-10 | Lilly Co Eli | Improvements in or relating to aqueous suspensions of procaine penicillin |
| US2897120A (en) * | 1954-05-04 | 1959-07-28 | Upjohn Co | Low viscosity cmc pharmaceutical vehicle |
| US2939818A (en) * | 1957-04-09 | 1960-06-07 | Pfizer & Co C | Aqueous therapeutic compositions |
| US3062718A (en) * | 1959-10-27 | 1962-11-06 | Pfizer & Co C | Stable aqueous streptomycinpenicillin composition |
| BE719923A (sv) * | 1964-05-20 | 1969-02-24 | ||
| IL31431A (en) * | 1968-01-18 | 1973-05-31 | Bristol Myers Co | Therapeutic compositions containing penicillin derivatives |
| GB1241844A (en) * | 1968-08-23 | 1971-08-04 | Beecham Group Ltd | Penicillins |
| US3634586A (en) * | 1968-12-04 | 1972-01-11 | Bristol Myers Co | Stable aqueous suspensions of ampicillin |
| US3703511A (en) * | 1969-06-06 | 1972-11-21 | Squibb & Sons Inc | Alpha-aminobenzyl penicillins |
| US3737545A (en) * | 1972-02-22 | 1973-06-05 | Squibb & Sons Inc | Alpha-aminobenzyl penicillins |
| GB1403584A (en) * | 1972-05-19 | 1975-08-28 | Beecham Group Ltd | Control medicaments |
| US3969524A (en) * | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
| DE2965732D1 (en) * | 1978-12-08 | 1983-07-28 | Beecham Group Plc | Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition |
-
1975
- 1975-03-07 GB GB9515/75A patent/GB1532993A/en not_active Expired
-
1976
- 1976-02-09 NZ NZ179948A patent/NZ179948A/xx unknown
- 1976-02-10 IE IE261/76A patent/IE42951B1/en unknown
- 1976-02-10 GR GR50009A patent/GR59302B/el unknown
- 1976-02-10 IL IL49009A patent/IL49009A/xx unknown
- 1976-02-11 SE SE7601535A patent/SE425762B/sv not_active IP Right Cessation
- 1976-02-13 ZM ZM20/76A patent/ZM2076A1/xx unknown
- 1976-02-17 ZA ZA926A patent/ZA76926B/xx unknown
- 1976-02-18 PT PT64813A patent/PT64813B/pt unknown
- 1976-02-25 HU HUBE1262A patent/HU170250B/hu unknown
- 1976-02-26 FI FI760503A patent/FI760503A7/fi not_active Application Discontinuation
- 1976-02-26 AR AR262385A patent/AR211700A1/es active
- 1976-02-27 DE DE2608079A patent/DE2608079C2/de not_active Expired
- 1976-02-27 FR FR7605542A patent/FR2302736A1/fr active Granted
- 1976-03-01 CA CA246,820A patent/CA1045549A/en not_active Expired
- 1976-03-02 BE BE164789A patent/BE839109A/xx not_active IP Right Cessation
- 1976-03-03 AT AT156576A patent/AT344317B/de not_active IP Right Cessation
- 1976-03-03 NL NLAANVRAGE7602180,A patent/NL187835C/xx not_active IP Right Cessation
- 1976-03-05 DK DK098076A patent/DK153123C/da not_active IP Right Cessation
- 1976-03-05 NO NO760767A patent/NO760767L/no unknown
- 1976-03-05 MX MX7643U patent/MX5599E/es unknown
- 1976-03-05 IT IT48427/76A patent/IT1061681B/it active
- 1976-03-05 DD DD191720A patent/DD124866A5/xx unknown
- 1976-03-08 JP JP51024278A patent/JPS5914004B2/ja not_active Expired
- 1976-03-08 AU AU11789/76A patent/AU502790B2/en not_active Expired
-
1987
- 1987-09-17 US US07/098,326 patent/US4876086A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE20518T1 (de) | Trockene pulverige allergenzusammensetzung und verfahren zu deren herstellung. | |
| HUT60630A (en) | Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature | |
| KR900015754A (ko) | 전암 병소 전신요법용의 적어도 1종의 사이토킨을 함유하는 약제학적 조성물의 용도 | |
| SE9301290D0 (sv) | Anvaendning av en somatostatinanalog | |
| AU499034B2 (en) | Treatment of schizophrenia using admixture of neuroleptic drug and gabergic compound | |
| SE7601535L (sv) | Injicerbara antibiotiska kompositioner | |
| IE40860B1 (en) | Substituted benzamides | |
| ES8102141A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7 | |
| DE3484904D1 (de) | Arzneimittelzusammensetzungen ermaessigter toxizitaet. | |
| MX3783E (es) | Procedimiento para la preparacion de composiciones para el tratamiento de enfermedades bucales y dentales | |
| ATE79256T1 (de) | Zusammensetzung gegen coccidiosis. | |
| ATE200617T1 (de) | Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge | |
| IE45054L (en) | Veterinary composition | |
| SE8501532D0 (sv) | Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning | |
| ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
| KR880004810A (ko) | 소화성 궤양 치료제 | |
| GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
| FR2335222A1 (fr) | Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant | |
| KR870011135A (ko) | 시스-6-(4-아세트아닐리도)-8,9-디메톡시-2-메틸-1,2,3,4,4a,10b- 헥사이드로-벤조〔c〕〔1,6〕 나프티리딘으로 구성된 약학적 조성물 및 그것의 용도 | |
| IL94621A0 (en) | Pharmaceutical compositions containing vitamin a in association with various therapeutically active ingredients | |
| FR2283670A1 (fr) | Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant | |
| DK277387D0 (da) | Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom | |
| GB1507643A (en) | 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 | |
| BE881625A (fr) | Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7601535-3 Effective date: 19920904 Format of ref document f/p: F |